INVESTORS & MEDIA
News Release
Regeneron Debuts on Prestigious Dow Jones Sustainability World Index of Most Sustainable Companies
"At Regeneron, our mission is to harness the power of science to help people with serious diseases. Our commitment to sustainable business practices is critical to delivering on this mission and to positively impacting society," said
DJSI World is considered the gold standard for measuring corporate ESG practices. It is published by S&P Dow Jones Indices, one of the world's leading index providers, together with RobecoSAM, which specializes in ESG data and benchmarking. This year, more than 4,500 global companies were invited to participate in the evaluation process.
"We are excited to be recognized on DJSI World alongside other global leaders in corporate responsibility," said
Regeneron publishes an annual Responsibility Report that provides an overview of our progress on sustainability. In addition to DJSI World, Regeneron has received a number of other recognitions, including The Civic 50, a list of the 50 most community-minded companies in
About Regeneron Pharmaceuticals, Inc.
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
Regeneron Contacts:
Media Relations
Tel : +1 (914) 847-3407
Alexandra.bowie@regeneron.com
Investor Relations
Tel: +1 (914) 847-7786
Justin.Holko@regeneron.com
View original content:http://www.prnewswire.com/news-releases/regeneron-debuts-on-prestigious-dow-jones-sustainability-world-index-of-most-sustainable-companies-300919191.html
SOURCE